Slide 1Solian ® in schizophrenia an overview Slide 2 Mode of action Slide 3 IC.AMS.04.06.02 Solians D 2 -D 3 selectivity is consistent with atypicality The dopamine cortico-subcortical…
Slide 1IC.AMS.04.06.02 Scientific expert: Dr Philippe NUSS Saint Antoine Hospital, Paris Solian ® in schizophrenia an overview Slide 2 IC.AMS.04.06.02 The information displayed…
1. SCHIZOPHRENIA Psychopharmacology 2. Psychopharmacology The primary medical treatment for schizophrenia is PSYCHOPHARMACOLOGY.In the past: Electroconvulsive therapy…
Slide 1 EVIDENCE-BASED MENTAL HEALTH PRACTICES Anthony F. Lehman, M.D., M.S.P.H. Professor and Chair Department of Psychiatry University of Maryland Slide 2 10 Leading Causes…
Slide 1 Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor…
Schizophrenia and Aging: Myths and Reality Dilip V. Jeste, M.D. Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor…
Schizophrenia and Aging: Myths and Reality Dilip V. Jeste, M.D. Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor…
characterized by positive and negative symptoms positive symptoms â those that can be observed; ex. hallucinations negative symptoms â absence of normal behaviors â lack…